Point72 Asset Management L.P. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | Point72 Asset Management L.P. | 44 0.100% | -27,798 (-99.84%) | Filing |
| 2021-05-18 4:30 pm Purchase | 2021-05-17 | 13G | Forte Biosciences, Inc. FBRX | Point72 Asset Management L.P. | 27,842 5.200% | 27,842 (New Position) | Filing |